TBS Over DLPFC in Elderly Refractory Depression

Last updated: January 13, 2023
Sponsor: Kaohsiung Veterans General Hospital.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression (Adult And Geriatric)

Depression

Depression (Major/severe)

Treatment

N/A

Clinical Study ID

NCT04872465
Kaohsiung VGHKS
  • Ages 60-85
  • All Genders

Study Summary

The study aim to examine the effect of Thea-burst stimulation over bilateral dorsolateral prefrontal cortex (DLPFC) among patients with LLD on mood condition and relevant biomarkers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Aged 60 to 85 years

  • Major depression disorder

  • Under a stable dose of all psychotropic medication during the stimulation period.

Exclusion Criteria

  • Having any current psychiatric comorbidity or history of substance dependence.

  • Having active suicidal ideation currently.

  • Having severe physical illness, recent and/or current unstable medical disorders.

  • Having history of cancer or chemotherapy.

  • Dementia or MMSE<24.

  • Having TMS contraindicated (seizure disorder, history of seizures, metal in the head, pacemakers, history of craniotomy)

Study Design

Total Participants: 60
Study Start date:
July 06, 2022
Estimated Completion Date:
July 31, 2024

Study Description

Thea-burst stimulation (TBS) is a novel form of rTMS, providing greater modulation effect on neural activity. So far, no study was conducted to use TBS as treatment in LLD. Therefore, we aim to examine the effect of TBS over bilateral dorsolateral prefrontal cortex (DLPFC) among patients with LLD on mood condition and relevant biomarkers. The study used a two-arm, parallel, double-blind, randomized, and sham-controlled design. We plan to enroll sixty patients with LLD, thirty for active intervention and thirty for sham-controlled group. An Magstim Rapid2 stimulator with eight-figure coil was used for stimulation. Location of brain area are based on bilateral DLPFC. 3-pulse 50-Hz bursts was given every 200ms (at 5 Hz) and an intensity of 80% active motor threshold was settled. We initially used cTBS (continuous TBS) over right DLPFC with 120-s train of uninterrupted bursts (1800 pulses) in each session per day. After that, we continuous use iTBS (intermittent TBS, iTBS) over left DLPFC with 2-s train of bursts was repeated every 10 s for a total of 570 s (1800 pulses). Each patient received daily stimulation for two weeks with total ten sessions. The primary outcomes were change of depression severity including response and remission rate. Secondary outcome were biomarkers related to depression. Assessments were administered at baseline, immediately after 5 and 10 sessions of stimulation, and 3 months after the completion of stimulation.

Connect with a study center

  • Department of Psychiatry, Kaohsiung Veterans General Hospital

    Kaohsiung, 813
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.